Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin - Summary - MDSpire
Clinical Guidelines

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. According to the American Cancer Society, in 2025, about 154,270 individ...

Share

Colorectal cancer ranks as the third most prevalent cancer in the U.S., with over 154,000 diagnoses anticipated in 2025. While low-dose aspirin has been studied for its preventative effects, its side effects diminish its recommendation. New evidence indicates that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce colorectal cancer risk by 36% compared to aspirin. A comprehensive study revealed that GLP-1RAs not only offer a favorable safety profile but could represent a significant advancement in cancer prevention strategies, urging further research.

Original Source(s)

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

  • by Jo Cavallo

  • April 24, 2026

Related Content

AI-Driven Multiagent System for Guiding First-Line Immunotherapy for NSCLC

An artificial intelligence (AI) multiagent system demonstrated correct and complete reasoning in determining the use of immunotherapy for patients with non–small cell lung cancer (NSCLC) in the first-...

Ulrich Steidl, MD, PhD, Named Director of Montefiore Einstein Comprehensive Cancer Center

An international leader in blood cancer and stem cell research has been named Director of the Montefiore Einstein Comprehensive Cancer Center and Vice President of Cancer Medicine at Montefiore Einste...

Dietary Influence on Leukemia and Lymphoma Progression

In 2015, LH, a 66-year-old female, was diagnosed with chronic lymphocytic leukemia (CLL), Rai stage 0. Untreated, the woman’s lymphocyte count rose from 5,000/mm3 to 16,000/mm3 in 6 years (doubling ti...